| Item Type | Name |
|
Concept
|
Antigen-Antibody Complex
|
|
Concept
|
Aggression
|
|
Concept
|
Ethanol
|
|
Concept
|
Amphetamines
|
|
Concept
|
Avoidance Learning
|
|
Concept
|
Adenylyl Cyclases
|
|
Concept
|
Cyclic AMP
|
|
Concept
|
Amino Acids
|
|
Concept
|
Analgesics, Opioid
|
|
Concept
|
Carbazoles
|
|
Concept
|
Central Nervous System Agents
|
|
Concept
|
Amphetamine
|
|
Concept
|
Anesthetics, Local
|
|
Concept
|
Apomorphine
|
|
Concept
|
Central Nervous System Stimulants
|
|
Concept
|
Analysis of Variance
|
|
Concept
|
Conditioning, Classical
|
|
Concept
|
Benzoates
|
|
Concept
|
Aspartic Acid
|
|
Concept
|
Association
|
|
Concept
|
Association Learning
|
|
Concept
|
Choice Behavior
|
|
Concept
|
Body Temperature Regulation
|
|
Concept
|
Benzylamines
|
|
Concept
|
Brain Mapping
|
|
Concept
|
Extinction, Psychological
|
|
Concept
|
Cerebellum
|
|
Concept
|
Central Nervous System Depressants
|
|
Concept
|
Corticosterone
|
|
Concept
|
Cues
|
|
Concept
|
Complement C3
|
|
Concept
|
Drug Synergism
|
|
Concept
|
Discrimination Learning
|
|
Concept
|
Injections, Intraperitoneal
|
|
Concept
|
Cycloleucine
|
|
Concept
|
Cytoskeleton
|
|
Concept
|
Isoproterenol
|
|
Concept
|
Enkephalins
|
|
Concept
|
Hydroxydopamines
|
|
Concept
|
Enzyme Inhibitors
|
|
Concept
|
Limbic System
|
|
Concept
|
Heroin
|
|
Concept
|
Chromatography, High Pressure Liquid
|
|
Concept
|
Evoked Potentials, Visual
|
|
Concept
|
Cocaine
|
|
Concept
|
Corpus Striatum
|
|
Concept
|
Dextroamphetamine
|
|
Concept
|
Drug Administration Routes
|
|
Concept
|
Indoles
|
|
Concept
|
Gene Expression Regulation
|
|
Concept
|
Dicarboxylic Acids
|
|
Concept
|
Hippocampus
|
|
Concept
|
Hormone Antagonists
|
|
Concept
|
Dopamine
|
|
Concept
|
Housing, Animal
|
|
Concept
|
Hydroxyindoleacetic Acid
|
|
Concept
|
Infusions, Intravenous
|
|
Concept
|
Heroin Dependence
|
|
Concept
|
Homovanillic Acid
|
|
Concept
|
Naltrexone
|
|
Concept
|
Narcotics
|
|
Concept
|
Immunohistochemistry
|
|
Concept
|
Injections, Intraventricular
|
|
Concept
|
Organ Culture Techniques
|
|
Concept
|
Methamphetamine
|
|
Concept
|
Mice, Inbred C57BL
|
|
Concept
|
Mutation
|
|
Concept
|
Saccharin
|
|
Concept
|
Spinal Puncture
|
|
Concept
|
Naloxone
|
|
Concept
|
Narcotic Antagonists
|
|
Concept
|
Sulpiride
|
|
Concept
|
Premedication
|
|
Concept
|
Protein Processing, Post-Translational
|
|
Concept
|
Psychomotor Performance
|
|
Concept
|
Forecasting
|
|
Concept
|
Gambling
|
|
Concept
|
Glutamates
|
|
Concept
|
Immunoglobulin G
|
|
Concept
|
Rats, Inbred F344
|
|
Concept
|
Complement Factor B
|
|
Concept
|
Risk Factors
|
|
Concept
|
Punishment
|
|
Concept
|
Pyrrolidines
|
|
Concept
|
Receptors, Cholinergic
|
|
Concept
|
Reinforcement Schedule
|
|
Concept
|
Restraint, Physical
|
|
Concept
|
Reward
|
|
Concept
|
Sensitivity and Specificity
|
|
Concept
|
Septal Nuclei
|
|
Concept
|
Sweetening Agents
|
|
Concept
|
Humans
|
|
Concept
|
Linear Models
|
|
Concept
|
Receptors, N-Methyl-D-Aspartate
|
|
Concept
|
Synapses
|
|
Concept
|
Statistics as Topic
|
|
Concept
|
Indans
|
|
Concept
|
Injections, Intravenous
|
|
Concept
|
Dronabinol
|
|
Concept
|
Substantia Nigra
|
|
Concept
|
Tegmentum Mesencephali
|
|
Concept
|
Tyrosine 3-Monooxygenase
|
|
Concept
|
Locomotion
|
|
Concept
|
Transduction, Genetic
|
|
Concept
|
Neurotransmitter Uptake Inhibitors
|
|
Concept
|
Glutamic Acid
|
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
|
Concept
|
Guanine Nucleotide Exchange Factors
|
|
Concept
|
Extracellular Matrix Proteins
|
|
Concept
|
Up-Regulation
|
|
Concept
|
3,4-Dihydroxyphenylacetic Acid
|
|
Concept
|
Metergoline
|
|
Concept
|
Mifepristone
|
|
Concept
|
Microinjections
|
|
Concept
|
Morphine
|
|
Concept
|
Complement C3d
|
|
Concept
|
Rats, Sprague-Dawley
|
|
Concept
|
Genes, Immediate-Early
|
|
Concept
|
Motor Activity
|
|
Concept
|
Point Mutation
|
|
Concept
|
Gene Transfer Techniques
|
|
Concept
|
Neostriatum
|
|
Concept
|
Mice, Knockout
|
|
Concept
|
Excitatory Amino Acid Antagonists
|
|
Concept
|
Receptors, AMPA
|
|
Concept
|
Excitatory Amino Acid Agents
|
|
Concept
|
Mice, Inbred MRL lpr
|
|
Concept
|
Caspase 3
|
|
Concept
|
Excitatory Amino Acid Agonists
|
|
Concept
|
Parkinson Disease
|
|
Concept
|
Nucleus Accumbens
|
|
Concept
|
Receptors, Dopamine D1
|
|
Concept
|
Raclopride
|
|
Concept
|
Autoreceptors
|
|
Concept
|
Positron-Emission Tomography
|
|
Concept
|
Casein Kinase Idelta
|
|
Concept
|
Leptin
|
|
Concept
|
Lupus Vasculitis, Central Nervous System
|
|
Concept
|
STAT3 Transcription Factor
|
|
Concept
|
Mice
|
|
Concept
|
Pyrimidines
|
|
Concept
|
Receptors, Dopamine
|
|
Concept
|
Receptors, Nicotinic
|
|
Concept
|
Raphe Nuclei
|
|
Concept
|
Rats, Inbred Strains
|
|
Concept
|
Selegiline
|
|
Concept
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2
|
|
Concept
|
Uncertainty
|
|
Concept
|
HEK293 Cells
|
|
Concept
|
Rats
|
|
Concept
|
Space Perception
|
|
Concept
|
Immunoblotting
|
|
Concept
|
PTEN Phosphohydrolase
|
|
Concept
|
Oxidopamine
|
|
Concept
|
Post-Synaptic Density
|
|
Concept
|
Dopamine and cAMP-Regulated Phosphoprotein 32
|
|
Concept
|
Xanthenes
|
|
Concept
|
Receptors, Glutamate
|
|
Concept
|
Ventral Tegmental Area
|
|
Concept
|
Gene Expression Regulation, Enzymologic
|
|
Concept
|
Long-Term Potentiation
|
|
Concept
|
Simplexvirus
|
|
Concept
|
Dopamine Uptake Inhibitors
|
|
Concept
|
Inhibitory Postsynaptic Potentials
|
|
Concept
|
Receptors, Kainic Acid
|
|
Concept
|
Receptors, Metabotropic Glutamate
|
|
Concept
|
Halorhodopsins
|
|
Concept
|
Quinpirole
|
|
Concept
|
Rats, Long-Evans
|
|
Concept
|
Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
|
|
Concept
|
Infusions, Intraventricular
|
|
Concept
|
Genome-Wide Association Study
|
|
Concept
|
CREB-Binding Protein
|
|
Concept
|
Conditioning, Operant
|
|
Concept
|
Dioxanes
|
|
Concept
|
Disease Models, Animal
|
|
Concept
|
Drug Administration Schedule
|
|
Concept
|
Fever
|
|
Concept
|
Hyperkinesis
|
|
Concept
|
Injections
|
|
Concept
|
Magnetic Resonance Imaging
|
|
Concept
|
Nicotine
|
|
Concept
|
Norepinephrine
|
|
Concept
|
Phenoxybenzamine
|
|
Concept
|
Psychotropic Drugs
|
|
Concept
|
Receptors, Adrenergic
|
|
Concept
|
Receptors, Adrenergic, beta
|
|
Concept
|
Self Administration
|
|
Concept
|
Receptors, Dopamine D2
|
|
Concept
|
Microdialysis
|
|
Concept
|
Presynaptic Terminals
|
|
Concept
|
Cyclic AMP-Dependent Protein Kinases
|
|
Concept
|
Receptors, Adrenergic, alpha-1
|
|
Concept
|
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
|
|
Concept
|
Polymorphism, Single Nucleotide
|
|
Concept
|
Quantitative Trait Loci
|
|
Concept
|
Tissue Culture Techniques
|
|
Concept
|
Microscopy, Electron, Transmission
|
|
Concept
|
Protein Kinase Inhibitors
|
|
Concept
|
Dopamine Plasma Membrane Transport Proteins
|
|
Concept
|
Proto-Oncogene Proteins c-akt
|
|
Concept
|
Cyclin-Dependent Kinase 5
|
|
Academic Article
|
Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat.
|
|
Academic Article
|
Metabotropic glutamate receptors in the rat nucleus accumbens contribute to amphetamine-induced locomotion.
|
|
Academic Article
|
Metabotropic glutamate receptors are necessary for sensitization by amphetamine.
|
|
Academic Article
|
Blockade of glutamate reuptake in the rat nucleus accumbens increases locomotor activity.
|
|
Academic Article
|
Group II, but not group I, metabotropic glutamate receptors in the rat nucleus accumbens contribute to amphetamine-induced locomotion.
|
|
Academic Article
|
The metabotropic glutamate receptor antagonist (RS)-MCPG produces hyperlocomotion in amphetamine pre-exposed rats.
|
|
Academic Article
|
Nicotine and morphine differentially activate brain dopamine in prefrontocortical and subcortical terminal fields: effects of acute and repeated injections.
|
|
Academic Article
|
The effect of previous exposure to amphetamine on drug-induced locomotion and self-administration of a low dose of the drug.
|
|
Academic Article
|
Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine.
|
|
Academic Article
|
Previous exposure to amphetamine enhances the subsequent locomotor response to a D1 dopamine receptor agonist when glutamate reuptake is inhibited.
|
|
Academic Article
|
The mGlu2/3 receptor agonist LY379268 blocks the expression of locomotor sensitization by amphetamine.
|
|
Academic Article
|
Behavioral sensitization to quinpirole is not associated with increased nucleus accumbens dopamine overflow.
|
|
Academic Article
|
Previous exposure to VTA amphetamine enhances cocaine self-administration under a progressive ratio schedule in an NMDA, AMPA/kainate, and metabotropic glutamate receptor-dependent manner.
|
|
Academic Article
|
Microinjection of CART peptide 55-102 into the nucleus accumbens blocks amphetamine-induced locomotion.
|
|
Academic Article
|
Previous exposure to psychostimulants enhances the reinstatement of cocaine seeking by nucleus accumbens AMPA.
|
|
Academic Article
|
Blockade of D2 dopamine receptors in the VTA induces a long-lasting enhancement of the locomotor activating effects of amphetamine.
|
|
Academic Article
|
Blockade of group II metabotropic glutamate receptors in the nucleus accumbens produces hyperlocomotion in rats previously exposed to amphetamine.
|
|
Academic Article
|
Absence of functional alternative complement pathway alleviates lupus cerebritis.
|
|
Academic Article
|
Exposure to nicotine and sensitization of nicotine-induced behaviors.
|
|
Academic Article
|
Amphetamine-induced changes in dendritic morphology in rat forebrain correspond to associative drug conditioning rather than nonassociative drug sensitization.
|
|
Academic Article
|
A role for casein kinase 1 epsilon in the locomotor stimulant response to methamphetamine.
|
|
Academic Article
|
Blockade of group II, but not group I, mGluRs in the rat nucleus accumbens inhibits the expression of conditioned hyperactivity in an amphetamine-associated environment.
|
|
Academic Article
|
Inhibition of CaMKII in the nucleus accumbens shell decreases enhanced amphetamine intake in sensitized rats.
|
|
Academic Article
|
Transient overexpression of alpha-Ca2+/calmodulin-dependent protein kinase II in the nucleus accumbens shell enhances behavioral responding to amphetamine.
|
|
Academic Article
|
Appetitive sensitization by amphetamine does not reduce its ability to produce conditioned taste aversion to saccharin.
|
|
Academic Article
|
The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine.
|
|
Academic Article
|
Enhanced nicotinic receptor function and drug abuse vulnerability.
|
|
Academic Article
|
Casein kinase 1 enables nucleus accumbens amphetamine-induced locomotion by regulating AMPA receptor phosphorylation.
|
|
Academic Article
|
Sensitization, drug addiction and psychopathology in animals and humans.
|
|
Academic Article
|
Activation of group II mGlu receptors blocks the enhanced drug taking induced by previous exposure to amphetamine.
|
|
Academic Article
|
Environment-specific cross-sensitization between the locomotor activating effects of morphine and amphetamine.
|
|
Academic Article
|
Conditioning and place-specific sensitization of increases in activity induced by morphine in the VTA.
|
|
Academic Article
|
Conditioned locomotion and place preference elicited by tactile cues paired exclusively with morphine in an open field.
|
|
Academic Article
|
Dorsal as well as ventral striatal lesions affect levels of intravenous cocaine and morphine self-administration in rats.
|
|
Academic Article
|
Sensitization occurs to the locomotor effects of morphine and the specific mu opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens.
|
|
Academic Article
|
Previous exposure to delta9-tetrahydrocannibinol enhances locomotor responding to but not self-administration of amphetamine.
|
|
Academic Article
|
Previous exposure to nicotine enhances the incentive motivational effects of amphetamine via nicotine-associated contextual stimuli.
|
|
Academic Article
|
Transient viral-mediated overexpression of alpha-calcium/calmodulin-dependent protein kinase II in the nucleus accumbens shell leads to long-lasting functional upregulation of alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors: dopamine type-1 receptor and protein kinase A dependence.
|
|
Academic Article
|
Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine.
|
|
Academic Article
|
Unpredictable saccharin reinforcement enhances locomotor responding to amphetamine.
|
|
Academic Article
|
a-1 Adrenergic receptors are localized on presynaptic elements in the nucleus accumbens and regulate mesolimbic dopamine transmission.
|
|
Academic Article
|
Morphine conditioned place preference and locomotion: the effect of confinement during training.
|
|
Academic Article
|
A comparison of the effects of intra-accumbens injections of amphetamine and morphine on reinstatement of heroin intravenous self-administration behavior.
|
|
Academic Article
|
Induction of locomotor sensitization by amphetamine requires the activation of NMDA receptors in the rat ventral tegmental area.
|
|
Academic Article
|
Repeated ventral tegmental area amphetamine administration alters dopamine D1 receptor signaling in the nucleus accumbens.
|
|
Academic Article
|
Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs.
|
|
Academic Article
|
The PKC inhibitor Ro31-8220 blocks acute amphetamine-induced dopamine overflow in the nucleus accumbens.
|
|
Academic Article
|
Enhanced dorsolateral striatal activity in drug use: the role of outcome in stimulus-response associations.
|
|
Academic Article
|
Hyperthermia induced by morphine administration to the VTA of the rat brain: an effect dissociable from morphine-induced reward and hyperactivity.
|
|
Academic Article
|
Intermittent nicotine exposure upregulates nAChRs in VTA dopamine neurons and sensitises locomotor responding to the drug.
|
|
Academic Article
|
Cerebrospinal fluid glutamate concentration correlates with impulsive aggression in human subjects.
|
|
Academic Article
|
Persistent reversal of enhanced amphetamine intake by transient CaMKII inhibition.
|
|
Academic Article
|
Excitatory synaptic function and plasticity is persistently altered in ventral tegmental area dopamine neurons after prenatal ethanol exposure.
|
|
Academic Article
|
Dopamine ups and downs in vulnerability to addictions: a neurodevelopmental model.
|
|
Academic Article
|
Striatal ups and downs: their roles in vulnerability to addictions in humans.
|
|
Academic Article
|
Drug-Paired Contextual Stimuli Increase Dendritic Spine Dynamics in Select Nucleus Accumbens Neurons.
|
|
Academic Article
|
Sensitizing exposure to amphetamine increases AMPA receptor phosphorylation without increasing cell surface expression in the rat nucleus accumbens.
|
|
Academic Article
|
Operant responding for optogenetic excitation of LDTg inputs to the VTA requires D1 and D2 dopamine receptor activation in the NAcc.
|
|
Academic Article
|
Leptin in the nucleus accumbens core disrupts acute cocaine effects: Implications for GSK3ß connections.
|
|
Academic Article
|
Exposure to conditions of uncertainty promotes the pursuit of amphetamine.
|
|
Academic Article
|
Environmental enrichment reverses increased addiction risk caused by prenatal ethanol exposure.
|
|
Academic Article
|
Prenatal ethanol exposure increases risk of psychostimulant addiction.
|
|
Academic Article
|
Maladaptive consequences of repeated intermittent exposure to uncertainty.
|
|
Academic Article
|
An overview of commonalities in the mechanisms underlying gambling and substance use disorders.
|
|
Academic Article
|
Sex-specific nicotine sensitization and imprinting of self-administration in rats inform GWAS findings on human addiction phenotypes.
|
|
Academic Article
|
Conditioned inhibition of amphetamine sensitization.
|
|
Academic Article
|
Glutamate inputs from the laterodorsal tegmental nucleus to the ventral tegmental area are essential for the induction of cocaine sensitization in male mice.
|
|
Concept
|
Glycogen Synthase Kinase 3 beta
|
|
Concept
|
Channelrhodopsins
|
|
Concept
|
Optogenetics
|
|
Concept
|
Fetal Alcohol Spectrum Disorders
|
|
Concept
|
In Vitro Techniques
|
|
Grant
|
DOPAMINE NEUROTRANSMISSION AND AMPHETAMINE SENSITIZATION
|